These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 10433937)

  • 1. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas.
    Streit M; Velasco P; Brown LF; Skobe M; Richard L; Riccardi L; Lawler J; Detmar M
    Am J Pathol; 1999 Aug; 155(2):441-52. PubMed ID: 10433937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo.
    Noh YH; Matsuda K; Hong YK; Kunstfeld R; Riccardi L; Koch M; Oura H; Dadras SS; Streit M; Detmar M
    J Invest Dermatol; 2003 Dec; 121(6):1536-43. PubMed ID: 14675207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis.
    Streit M; Riccardi L; Velasco P; Brown LF; Hawighorst T; Bornstein P; Detmar M
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14888-93. PubMed ID: 10611308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
    Jeanne A; Sick E; Devy J; Floquet N; Belloy N; Theret L; Boulagnon-Rombi C; Diebold MD; Dauchez M; Martiny L; Schneider C; Dedieu S
    Oncotarget; 2015 Jul; 6(20):17981-8000. PubMed ID: 26046793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of thrombospondin-1 reduces growth and vascular index but not perfusion in glioblastoma.
    Kragh M; Quistorff B; Tenan M; Van Meir EG; Kristjansen PE
    Cancer Res; 2002 Feb; 62(4):1191-5. PubMed ID: 11861403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization.
    Bleuel K; Popp S; Fusenig NE; Stanbridge EJ; Boukamp P
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2065-70. PubMed ID: 10051595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
    García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice.
    Hawighorst T; Oura H; Streit M; Janes L; Nguyen L; Brown LF; Oliver G; Jackson DG; Detmar M
    Oncogene; 2002 Nov; 21(52):7945-56. PubMed ID: 12439745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of an anti-angiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenografts.
    Jin RJ; Kwak C; Lee SG; Lee CH; Soo CG; Park MS; Lee E; Lee SE
    Cancer Gene Ther; 2000 Dec; 7(12):1537-42. PubMed ID: 11228532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats.
    Tei K; Kawakami-Kimura N; Taguchi O; Kumamoto K; Higashiyama S; Taniguchi N; Toda K; Kawata R; Hisa Y; Kannagi R
    Cancer Res; 2002 Nov; 62(21):6289-96. PubMed ID: 12414659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics.
    Reiher FK; Volpert OV; Jimenez B; Crawford SE; Dinney CP; Henkin J; Haviv F; Bouck NP; Campbell SC
    Int J Cancer; 2002 Apr; 98(5):682-9. PubMed ID: 11920636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of tumor angiogenesis by thrombospondin-1.
    Ren B; Yee KO; Lawler J; Khosravi-Far R
    Biochim Biophys Acta; 2006 Apr; 1765(2):178-88. PubMed ID: 16406676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo.
    Bongrazio M; Da Silva-Azevedo L; Bergmann EC; Baum O; Hinz B; Pries AR; Zakrzewicz A
    Int J Immunopathol Pharmacol; 2006; 19(1):35-48. PubMed ID: 16569344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin-2 overexpression in the skin of transgenic mice reduces the susceptibility to chemically induced multistep skin carcinogenesis.
    Kunstfeld R; Hawighorst T; Streit M; Hong YK; Nguyen L; Brown LF; Detmar M
    J Dermatol Sci; 2014 May; 74(2):106-15. PubMed ID: 24507936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
    Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P
    Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiogenesis inhibitor thrombospondin-1 inhibits acute cutaneous hypersensitivity reactions.
    Velasco P; Huegel R; Brasch J; Schröder JM; Weichenthal M; Stockfleth E; Schwarz T; Lawler J; Detmar M; Lange-Asschenfeldt B
    J Invest Dermatol; 2009 Aug; 129(8):2022-30. PubMed ID: 19194474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy.
    Li M; Ye C; Feng C; Riedel F; Liu X; Zeng Q; Grandis JR
    Clin Cancer Res; 2002 Nov; 8(11):3570-8. PubMed ID: 12429648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of CD36 molecular features required for its in vitro angiostatic activity.
    Primo L; Ferrandi C; Roca C; Marchiò S; di Blasio L; Alessio M; Bussolino F
    FASEB J; 2005 Oct; 19(12):1713-5. PubMed ID: 16037098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the type-1 repeats of thrombospondin-1 inhibits tumor growth through activation of transforming growth factor-beta.
    Yee KO; Streit M; Hawighorst T; Detmar M; Lawler J
    Am J Pathol; 2004 Aug; 165(2):541-52. PubMed ID: 15277228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic inhibition of tumor growth and angiogenesis by thrombospondin-2 using cell-based antiangiogenic gene therapy.
    Streit M; Stephen AE; Hawighorst T; Matsuda K; Lange-Asschenfeldt B; Brown LF; Vacanti JP; Detmar M
    Cancer Res; 2002 Apr; 62(7):2004-12. PubMed ID: 11929817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.